All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Monitoring of plasma circulating donor DNA reflects cardiac graft injury: Report of two cases

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F86652036%3A_____%2F24%3A00583677" target="_blank" >RIV/86652036:_____/24:00583677 - isvavai.cz</a>

  • Alternative codes found

    RIV/00216208:11110/24:10482788 RIV/00216208:11310/24:10482788 RIV/00023001:_____/24:00084682

  • Result on the web

    <a href="https://www.spandidos-publications.com/10.3892/br.2024.1738" target="_blank" >https://www.spandidos-publications.com/10.3892/br.2024.1738</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.3892/br.2024.1738" target="_blank" >10.3892/br.2024.1738</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Monitoring of plasma circulating donor DNA reflects cardiac graft injury: Report of two cases

  • Original language description

    The current standard for graft rejection surveillance is endomyocardial biopsy (EMB), an invasive procedure with rare but potentially serious complications. Detection of circulating donor-derived cell-free DNA (ddcfDNA) is an option for noninvasive monitoring of graft injury and rejection. A 63-year-old man and a 65-year-old woman were monitored by EMB for allograft rejection. A total of 48 single-nucleotide polymorphisms with a minor allele frequency range of 0.4-0.5 were screened to distinguish donor and recipient DNA based on homozygosity, and digital droplet PCR was used to analyze ddcfDNA concentrations. Both subjects suffered rejection within the first 6 months after transplantation. The maximal ddcfDNA level of 270 copies (cp)/ml during EMB-confirmed acute cellular rejection (ACR, mild grade 1R/2, patient 1), and the maximal concentration of 1,846 cp/ml in the case of EMB-confirmed antibody-mediated rejection (AMR, grade 1+, patient 2), was detected. Individual monitoring of ddcfDNA dynamics from the 1st to the 6th month posttransplant reflected cardiac graft injury in patients suffering ACR or AMR, meaning that ddcfDNA may serve as a noninvasive biomarker.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database

  • CEP classification

  • OECD FORD branch

    10608 - Biochemistry and molecular biology

Result continuities

  • Project

    <a href="/en/project/NU20-06-00061" target="_blank" >NU20-06-00061: The possibility of using free circulating gDNA and mtDNA in the detection of graft rejection after heart transplantation.</a><br>

  • Continuities

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2024

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Biomedical Reports

  • ISSN

    2049-9434

  • e-ISSN

    2049-9442

  • Volume of the periodical

    20

  • Issue of the periodical within the volume

    3

  • Country of publishing house

    GR - GREECE

  • Number of pages

    7

  • Pages from-to

    50

  • UT code for WoS article

    001162521300001

  • EID of the result in the Scopus database

    2-s2.0-85184431316